Clinical Trial Update: FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma [NA]

View source ↗

Summary

This update reports that the clinical trial examining FDG PET/CT for monitoring very early therapy response in glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Glioblastoma | NA | Status: COMPLETED